These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3665901)

  • 1. In vivo and in vitro activity of roxithromycin against Toxoplasma gondii in mice.
    Luft BJ
    Eur J Clin Microbiol; 1987 Aug; 6(4):479-81. PubMed ID: 3665901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice.
    Chan J; Luft BJ
    Antimicrob Agents Chemother; 1986 Aug; 30(2):323-4. PubMed ID: 3767344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of roxithromycin against Toxoplasma gondii in murine models.
    Chang HR; Pechère JC
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():69-74. PubMed ID: 3429388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
    Romand S; Bryskier A; Moutot M; Derouin F
    J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii.
    Chang HR; Pechère JC
    Antimicrob Agents Chemother; 1988 Apr; 32(4):524-9. PubMed ID: 2837140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice.
    Nguyen BT; Stadtsbaeder S
    Br J Pharmacol; 1983 Aug; 79(4):923-8. PubMed ID: 6606459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of roxithromycin on acute toxoplasmosis in mice.
    Chang HR; Pechere JC
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1147-9. PubMed ID: 3662475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
    Araujo FG; Shepard RM; Remington JS
    Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):519-24. PubMed ID: 1655433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis.
    El-Zawawy LA; El-Said D; Mossallam SF; Ramadan HS; Younis SS
    Exp Parasitol; 2015 Feb; 149():54-64. PubMed ID: 25499511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ponazuril in vitro and in preventing and treating Toxoplasma gondii infections in mice.
    Mitchell SM; Zajac AM; Davis WL; Lindsay DS
    J Parasitol; 2004 Jun; 90(3):639-42. PubMed ID: 15270113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection induced by virus-like particles containing Toxoplasma gondii microneme protein 8 against highly virulent RH strain of Toxoplasma gondii infection.
    Lee SH; Kim AR; Lee DH; Rubino I; Choi HJ; Quan FS
    PLoS One; 2017; 12(4):e0175644. PubMed ID: 28406951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The course of infection with Toxoplasma gondii RH strain in mice pre-vaccinated with gamma irradiated tachyzoites.
    Gomaa AM; El-Tantawy NL; Elsawey AM; Abdelsalam RA; Azab MS
    Exp Parasitol; 2019 Oct; 205():107733. PubMed ID: 31408623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of spiramycin against Toxoplasma gondii in vitro, in experimental infections and in human infection.
    Chang HR; Pechère JC
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():87-92. PubMed ID: 3182450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis.
    Montazeri M; Emami S; Asgarian-Omran H; Azizi S; Sharif M; Sarvi S; Rezaei F; Sadeghi M; Gohardehi S; Daryani A
    Exp Parasitol; 2019 May; 200():7-12. PubMed ID: 30904693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of mouse macrophage cell lines for in vitro propagation of Toxoplasma gondii RH tachyzoites.
    Chamberland S; Current WL
    Proc Soc Exp Biol Med; 1991 Jun; 197(2):150-7. PubMed ID: 2031052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection with Toxoplasma gondii RH and Prugniaud strains in mice, rats and nude rats: kinetics of infection in blood and tissues related to pathology in acute and chronic infection.
    Zenner L; Foulet A; Caudrelier Y; Darcy F; Gosselin B; Capron A; Cesbron-Delauw MF
    Pathol Res Pract; 1999; 195(7):475-85. PubMed ID: 10448664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two methods for attenuating Toxoplasma gondii tachyzoites RH strain by using ethanol extract of Curcuma longa.
    Al-Zanbagi NA; Zelai NT
    J Egypt Soc Parasitol; 2008 Dec; 38(3):965-76. PubMed ID: 19209778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifapentine is active in vitro and in vivo against Toxoplasma gondii.
    Araujo FG; Khan AA; Remington JS
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1335-7. PubMed ID: 8725996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis.
    Brun-Pascaud M; Chau F; Simonpoli AM; Girard PM; Derouin F; Pocidalo JJ
    J Infect Dis; 1994 Sep; 170(3):653-8. PubMed ID: 8077724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic resistance against acute toxoplasmosis depends on the strain of Toxoplasma gondii.
    Suzuki Y; Yang Q; Remington JS
    J Parasitol; 1995 Dec; 81(6):1032-4. PubMed ID: 8544050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.